GMP Pharmaceuticals and GMP Dairy provide investors with exposure to New Zealand’s high-value health, nutrition and premium dairy export sectors through established operating businesses.

Supported by more than 30 years of industry experience, the group combines integrated research and development, advanced manufacturing, rigorous quality control and an established international customer network.

GMP Pharmaceuticals is a leading contract manufacturer of health and nutritional products, while GMP Dairy produces premium milk powder to pharmaceutical-grade standards. The proposed expansion will increase production capacity across these complementary platforms, supported by end-to-end product traceability and New Zealand’s strong reputation for food safety and healthcare quality.

For investors considering the NZD 5 million Growth Category under New Zealand’s Active Investor Plus (AIP) Visa, GMP presents a growth-oriented opportunity supported by productive New Zealand businesses, scalable export potential and established operating capability.